We are live on
!
Find out more
HTC
Hershey Trust Company Portfolio holdings
AUM
$11.8B
1-Year Est. Return
0.75%
This Fund
S&P 500
This Quarter
Est. Return
-0.06%
1 Year Est. Return
+0.75%
3 Year Est. Return
-0.55%
5 Year Est. Return
-0.68%
10 Year Est. Return
+3.33%
AUM
$13.1B
AUM Growth
+$1.16B
(+9.8%)
Cap. Flow
-$224M
Cap. Flow
% of AUM
-1.71%
Top 10 Holdings %
Top 10 Hldgs %
99.84%
Holding
42
New
1
Increased
4
Reduced
6
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$2.06M |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$2.05M |
| 3 |
iShares US Transportation ETF
IYT
|
+$2.03M |
| 4 |
DIDI
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
|
+$142K |
| 5 |
DADA
Dada Nexus
DADA
|
+$128K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE Small-Cap ETF
SCZ
|
+$6.82M |
| 2 |
DoorDash
DASH
|
+$1.64M |
| 3 |
Doximity
DOCS
|
+$1.26M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.13M |
| 5 |
CELL
PhenomeX Inc. Common Stock
CELL
|
+$385K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 0.12% |
| 2 | Consumer Staples | 0.08% |
| 3 | Healthcare | 0.08% |
| 4 | Technology | 0.04% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alector
ALEC
$169M
| $73K | ﹤0.01% |
5,143
| – | – |
|
27
C3.ai
AI
$1.38B
| $61K | ﹤0.01% |
2,667
| – | – |
|
28
Century Therapeutics
IPSC
$364M
| $59K | ﹤0.01% |
4,723
| – | – |
|
29
Scholar Rock
SRRK
$5.88B
| $38K | ﹤0.01% |
2,914
| – | – |
|
30
Aligos Therapeutics
ALGS
$26.3M
| $10K | ﹤0.01% |
182
-61
| -25% | -$4.88K |
|
31
Crinetics Pharmaceuticals
CRNX
$8.88B
| – | – |
-7,521
| Closed | -$214K |
|
32
CrowdStrike
CRWD
$183B
| – | – |
-4,952
| Closed | -$253K |
|
|
33
iShares MSCI Emerging Markets ETF
EEM
$27.5B
| – | – |
-23,150
| Closed | -$1.13M |
|
34
Fulcrum Therapeutics
FULC
$241M
| – | – |
-7,903
| Closed | -$140K |
|
35
Moody's
MCO
$83.7B
| – | – |
-13
| Closed | -$5K |
|
36
PMV Pharmaceuticals
PMVP
$57.1M
| – | – |
-3,841
| Closed | -$89K |
|
|
GRTS
37
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| – | – |
-8,791
| Closed | -$113K |
|
|
CELL
38
DELISTED
PhenomeX Inc. Common Stock
CELL
| – | – |
-21,176
| Closed | -$385K |
|
|
OYST
39
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| – | – |
-3,003
| Closed | -$55K |
|
Similar funds
VA
BCI
VIA
NYLIM
PI
UE
LC
MG
Hershey Trust Company's Q1 2022 Portfolio in Review
As of Q1 2022, Hershey Trust Company held 42 positions worth $13.1B, up 9.8% from $11.9B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Hershey Trust Company's Q1 2022 filing shows 1 new, 4 increased, 6 reduced and 10 closed positions. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 36,072 shares worth $90K. The largest sale was iShares MSCI EAFE Small-Cap ETF, an estimated $6.82M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 0.12% of assets, down from 0.17% a quarter earlier, followed by Consumer Staples and Healthcare.
- Hershey Trust Company's largest Q1 2022 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 36,072 shares worth $90K.
- Hershey Trust Company added most to State Street Industrial Select Sector SPDR ETF in Q1 2022, an estimated $2.06M increase.
- Hershey Trust Company's biggest Q1 2022 reduction was iShares MSCI EAFE Small-Cap ETF, cutting an estimated $6.82M.
- Hershey Trust Company fully exited iShares MSCI Emerging Markets ETF in Q1 2022, selling an estimated $1.13M.
- Hershey Trust Company's ten largest holdings make up 100% of its $13.1B portfolio in Q1 2022.
- Hershey Trust Company opened 1 new position and closed 10 in Q1 2022.
- Hershey Trust Company's portfolio value rose 9.8% quarter-over-quarter to $13.1B.
Based on Hershey Trust Company's 13F filing for Q1 2022, filed 13 May 2022.